TY - JOUR AU - Grady, Caroline A. AU - Beau de Rochars, Madsen AU - Direny, Abdel N. AU - Orelus, Jean Nicolas AU - Wendt, Joyanna AU - Radday, Jeanne AU - Mathieu, Els AU - Roberts, Jacquelin M. AU - Streit, Thomas G. AU - Addiss, David G. AU - Lammie, Patrick J. T1 - Endpoints for Lymphatic Filariasis Programs T2 - Emerging Infectious Disease journal PY - 2007 VL - 13 IS - 4 SP - 608 SN - 1080-6059 AB - In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs. KW - lymphatic filariasis KW - mass drug administration KW - elimination KW - microfilaremia KW - Wuchereria bancrofti KW - diethylcarbamazine (DEC) KW - albendazole KW - dispatch KW - Haiti DO - 10.3201/eid1304.061063 UR - https://wwwnc.cdc.gov/eid/article/13/4/06-1063_article ER - End of Reference